ZHEJIANG SKYHERB BIOTECHNOLOGY INC. – Trademark Portfolio

Entity Type: 03

ZHEJIANG SKYHERB BIOTECHNOLOGY INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include GCBEST and SKYHERB. The owner is based in HUZHOU, ZHEJIANG.

BUILDING 1, TANGPU INDUSTRIAL ZONE

ANJI, ECONOMIC DEVELOPMENT ZONE

HUZHOU, ZHEJIANG 313000 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SKYHERB
SKYHERB
Registered 2013
NEUGRAPE
NEUGRAPE
Cancelled 2013
FITGRAPE
FITGRAPE
Cancelled 2013
GCBEST
GCBEST
Registered 2012
GCBEV
GCBEV
Cancelled 2012

Trademark Classifications

ZHEJIANG SKYHERB BIOTECHNOLOGY INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ZHEJIANG SKYHERB BIOTECHNOLOGY INC. have?

ZHEJIANG SKYHERB BIOTECHNOLOGY INC. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.

What trademark classes does ZHEJIANG SKYHERB BIOTECHNOLOGY INC. file in?

ZHEJIANG SKYHERB BIOTECHNOLOGY INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ZHEJIANG SKYHERB BIOTECHNOLOGY INC.'s most well-known trademarks?

ZHEJIANG SKYHERB BIOTECHNOLOGY INC.'s registered trademark portfolio includes well-known marks such as GCBEST and SKYHERB. These are among 2 currently registered trademarks in the portfolio.

What is ZHEJIANG SKYHERB BIOTECHNOLOGY INC.'s trademark registration success rate?

ZHEJIANG SKYHERB BIOTECHNOLOGY INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.